Evidence map›Paper›PMID 39337571›Full record

ArticleInternational journal of molecular sciences2024

CD68-Negative Histiocytoses with Cardiac Involvement, Associated with COVID-19.

Lubov Mitrofanova, Lubov Korneva, Igor Makarov, Maria Bortsova, Maria Sitnikova, Daria Ryzhkova, Dmitry Kudlay, Anna Starshinova

Abstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lubov MitrofanovaAlmazov National Medical Research Centre, 197341 St. Petersburg, Russia.
Lubov KornevaAlmazov National Medical Research Centre, 197341 St. Petersburg, Russia.
Igor MakarovAlmazov National Medical Research Centre, 197341 St. Petersburg, Russia.ORCID 0000-0001-6175-8403
Maria BortsovaAlmazov National Medical Research Centre, 197341 St. Petersburg, Russia.
Maria SitnikovaAlmazov National Medical Research Centre, 197341 St. Petersburg, Russia.
Daria RyzhkovaAlmazov National Medical Research Centre, 197341 St. Petersburg, Russia.
Dmitry KudlayDepartment of Pharmacognosy and Industrial Pharmacy, Faculty of Fundamental Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0003-1878-4467
Anna StarshinovaAlmazov National Medical Research Centre, 197341 St. Petersburg, Russia.ORCID 0000-0002-9023-6986

Funding

Almazov National Medical Research Centre of the Ministry of Health of Russian Federation 075-15-2022-301
6 · The paper itself

Abstract

Histiocytoses are rare diseases characterised by infiltration of affected organs by myeloid cells with a monocyte or dendritic cell phenotype. Symptoms can range from self-resolving localised forms to multisystemic lesions requiring specific treatment. To demonstrate extremely rare cases of CD68-negative cardiac histiocytosis with expression of SARS-CoV-2 antigen in infiltrate cells. We demonstrated a case of Erdheim-Chester disease in a 67-year-old man with pericardial involvement and positive dynamics with vemurafenib treatment, an autopsy case of xanthogranulomatous myopericarditis in a 63-year-old man, surgical material of xanthogranulomatous constrictive pericarditis in a 57-year-old man, and an autopsy case of xanthogranulomatosis in a 1-month-old girl. In all cases, xanthogranuloma cells expressed CD163, many of them spike protein SARS-CoV-2, while CD68 expression was detected only in single cells. In this article, we demonstrated four cases of extremely rare CD68-negative cardiac xanthogranulomatosis in three adults and one child with expression of the spike protein SARS-CoV-2 in M2 macrophages. This potential indirect association between COVID-19 and the development of histiocytosis in these patients warrants further investigation. To substantiate this hypothesis, more extensive research is needed.

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticCOVID-19HistiocytosisSARS-CoV-2AgedCD163 AntigenCD68 MoleculeErdheim-Chester DiseaseFemaleHumansInfantMaleMiddle AgedReceptors, Cell SurfaceSpike Glycoprotein, CoronavirusAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenCD68 antigen, humanCD68 MoleculeReceptors, Cell SurfaceSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2CD68COVID-19Erdheim–Chester diseasemyocarditispericarditisxanthogranulomatosis

Identifiers

PMID39337571
PMCPMC11432257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.